Plant-Produced SARS-CoV-2 Antibody Engineered Towards Enhanced Potency and In Vivo Efficacy

Investigators described the expression, production, and purification of the originally human COVA2-15 antibody in plants. Their plant-produced mAbs demonstrated comparable neutralizing activity with COVA2-15 produced in mammalian cells.